![Peter Weiler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Weiler
Finanzdirektor/CFO bei
EDESA BIOTECH, INC.
Vermögen: - $ am 31.05.2026
Profil
Peter J.
Weiler is President at Exzell Pharma, Inc. since 2018.
Mr. Weiler is Chief Financial Officer at Edesa Biotech, Inc. starting in 2025.
Formerly, Mr. Weiler was Senior Director-Analysis & Research at DRI Healthcare.
Mr. Weiler was Vice President-Business Development at BioSyent, Inc. from 2017 to 2018.
Mr. Weiler was Vice President-Business Development at Cipher Pharmaceuticals, Inc. from 2008 to 2017.
Education includes graduate studies at the University of Western Ontario and an MBA from Richard Ivey School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EDESA BIOTECH, INC. -.--% | 27.05.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Peter Weiler
| Unternehmen | Position | Beginn |
|---|---|---|
| EDESA BIOTECH, INC. | Finanzdirektor/CFO | 01.05.2025 |
Exzell Pharma, Inc.
 Exzell Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells OTC and prescription pharmaceutical products | Präsident | 01.08.2018 |
Ehemalige bekannte Positionen von Peter Weiler
| Unternehmen | Position | Ende |
|---|---|---|
| BIOSYENT INC. | Corporate Officer/Principal | 01.09.2018 |
| CIPHER PHARMACEUTICALS INC. | Corporate Officer/Principal | 01.05.2017 |
DRI Healthcare
 DRI Healthcare Investment ManagersFinance DRI Healthcare invests in royalty interests in leading pharmaceutical and biotechnology companies, research institutions, universities and inventors. | Corporate Officer/Principal | - |
Ausbildung von Peter Weiler
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
29
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
DRI Healthcare
DRI Healthcare Investment ManagersFinance DRI Healthcare invests in royalty interests in leading pharmaceutical and biotechnology companies, research institutions, universities and inventors. | Finance |
BioSyent, Inc.
 BioSyent, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Cipher Pharmaceuticals, Inc.
 Cipher Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Provides laboratory testing and medical imaging services | Health Technology |
University of Western Ontario
 University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Richard Ivey School of Business
 Richard Ivey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edesa Biotech, Inc.
 Edesa Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treatment of chronic allergic contact dermatitis | Health Technology |
Exzell Pharma, Inc.
Exzell Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells OTC and prescription pharmaceutical products | Health Technology |
